Skip to main content

Clinical Case 3: Patient with Diabetes Mellitus

  • Chapter
  • First Online:
Hypertension and Comorbidities

Part of the book series: Practical Case Studies in Hypertension Management ((PCSHM))

  • 1074 Accesses

Abstract

A 72-year-old, Caucasian female, retired (former schoolteacher), presented to the outpatient clinic for clinical assessment of uncontrolled hypertension. The patient refers history of essential hypertension by the menopause status (about 20 years ago). She was treated with unspecified drugs that she does not remember. By about 10 years, she is treated with an alpha-1 blocker (doxazosin, 2 mg/day) and a Ca-antagonist (amlodipine, 5 mg), with satisfactory home and office blood pressure control. By about 6 months, she reported elevated home blood pressure values, confirmed by his general practitioner. She added a thiazide diuretic, without any blood pressure changes. In the meantime, she never changed her usual daily pills intake or the drugs’ brand.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31(7):1281–357.

    Article  CAS  PubMed  Google Scholar 

  2. Wijkman M, Lanne T, Engvall J, Lindstrom T, Ostgren CJ, Nystrom FH. Masked nocturnal hypertension: a novel marker of risk in type 2 diabetes. Diabetologia. 2009;52:1258–64.

    Article  CAS  PubMed  Google Scholar 

  3. Zanchetti A. Blood pressure targets of antihypertensive treatment: up and down the J-shaped curve. Eur Heart J. 2010;31:2837–40.

    Article  CAS  PubMed  Google Scholar 

  4. The ACCORD Study Group. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362:1575–85.

    Article  PubMed Central  Google Scholar 

  5. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet. 1998;351:1755–62.

    Article  CAS  PubMed  Google Scholar 

  6. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br Med J. 1998;317:703–13.

    Article  Google Scholar 

  7. Schrier RW, Estacio RO, Esler A, Mehler P. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney Int. 2002;61:1086–97.

    Article  PubMed  Google Scholar 

  8. ADVANCE Collaborative Group. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet. 2007;370:829–40.

    Article  Google Scholar 

  9. Haller H, Ito S, Izzo Jr JL, Januszewicz A, Katayama S, Menne J, et al. ROADMAP Trial Investigators. Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. N Engl J Med. 2011;364:907–17.

    Article  CAS  PubMed  Google Scholar 

  10. Blood Pressure Lowering Treatment Trialists’ Collaboration. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. Arch Intern Med. 2005;165:1410–9.

    Article  Google Scholar 

  11. Schmieder RE, Hilgers KF, Schlaich MP, Schmidt BM. Renin-angiotensin system and cardiovascular risk. Lancet. 2007;369:1208–19.

    Article  CAS  PubMed  Google Scholar 

  12. Pearce JD, Craven BL, Craven TE, Piercy KT, Stafford JM, Edwards MS, Hansen KJ. Progression of atherosclerotic renovascular disease: A prospective population-based study. J Vasc Surg. 2006;44:955–62.

    Article  PubMed  Google Scholar 

  13. Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med. 2001;344:431–42.

    Article  CAS  PubMed  Google Scholar 

  14. Gray BH, Olin JW, Childs MB, Sullivan TM, Bacharach JM. Clinical benefit of renal artery angioplasty with stenting for the control of recurrent and refractory congestive heart failure. Vasc Med. 2002;7:275–9.

    Article  PubMed  Google Scholar 

  15. Wheatley K, Ives N, Gray R, Kalra PA, Moss JG, Baigent C, et al. Revascularization vs. medical therapy for renal-artery stenosis. N Engl J Med. 2009;361:1953–62.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Virdis, A. (2016). Clinical Case 3: Patient with Diabetes Mellitus. In: Hypertension and Comorbidities. Practical Case Studies in Hypertension Management. Springer, Cham. https://doi.org/10.1007/978-3-319-39164-9_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-39164-9_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-39163-2

  • Online ISBN: 978-3-319-39164-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics